The 100,000 Genomes project can help to create an NHS fit for the 21st century. Now researchers need to get involved, says George Freeman.
The government’s investment in the 100,000 Genomes project, which will sequence the DNA of 100,000 patients with cancer or a rare or infectious disease, gives the UK a good claim to be leading the world in genomics.
The medical case for the project is compelling. The World Health Organization has predicted that the number of new cancer cases will rise by about 70 per cent over the next 2 decades. Only a quarter of UK cases of rare diseases have a known molecular basis, and infection is one of the leading causes of death of hospital patients worldwide.
This article on Research Professional News is only available to Research Professional or Pivot-RP users.
Research Professional users can log in and view the article via this link
Pivot-RP users can log in and view the article via this link.